Barclays lowered CVS Health (NYSE:CVS) price target from $110 to $100

By / / Barclays

Barclays analyst Steven Valiquette maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $110 to $100.

Scroll to Top